Back to Journals » International Journal of Nanomedicine » Volume 18

Response on Article “A Sustained-Release Nanosystem with MRSA Biofilm-Dispersing and -Eradicating Abilities Accelerates Diabetic Ulcer Healing” [Response to Letter]

Authors Li Z 

Received 10 August 2023

Accepted for publication 11 August 2023

Published 17 August 2023 Volume 2023:18 Pages 4681—4682

DOI https://doi.org/10.2147/IJN.S434825



Zhiqing Li

Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of China

Correspondence: Zhiqing Li, Department of Burns, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of China, Email [email protected]


View the original paper by Miss He and colleagues

This is in response to the Letter to the Editor


Dear editor

Thank you for your appreciate of our published article “A Sustained-Release Nanosystem with MRSA Biofilm-Dispersing and -Eradicating Abilities Accelerates Diabetic Ulcer Healing”, which was just published in International Journal of Nanomedicine. In our study, TTO-NL@PCS ameliorates the chemotaxis disorder in early treatment and attenuates the wound inflammatory response during the repair stage of diabetic inflammatory wounds, and upregulates VEGF expression in the wound bed, which demonstrates the remarkable potential for accelerating diabetic and MRSA-infected wound healing. However, there are still some limitations existing in current studies. In the study, quantification of biofilm formation, which is a vital index to evaluate the antibacterial ability, should be applied and the skin tissue should be obtained from patients diagnosed with diabetes mellitus. We would improve these aspects in the future research, and please look forward to our research in the future.

Disclosure

The author reports no conflicts of interest in this communication.

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.